Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements

Company Overview - FOXO Technologies Inc. is a biotechnology company focused on improving human health and longevity through advanced technology and product solutions, particularly in the life insurance sector [8] - The company utilizes epigenetic technology and AI to analyze DNA methylation for identifying molecular biomarkers related to health and aging [8] Recent Developments - FOXO has filed its Form 10-Q for the quarter ended March 31, 2024, regaining compliance with SEC reporting requirements [1] - The company has successfully closed the Myrtle Recovery Centers transaction on June 14, 2024, and secured a commitment for up to $2.5 million in additional capital [6] - The acquisition of Scott County Community Hospital is pending shareholder approval and is expected to close in the third quarter of 2024 [7] Financial Performance - Myrtle Recovery Centers anticipates generating annual revenues of approximately $3-4 million and aims to replicate its business model in other locations [2] - Scott County Community Hospital and Myrtle Recovery Centers reported unaudited net revenue of approximately $18.7 million and net income of approximately $5.2 million for the twelve months ended December 31, 2023 [3]